FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Salmeterol is a long-acting beta-2 agonist which is used in the treatment of asthma as an adjunct to inhaled corticosteroids.
The long-lasting action of salmeterol means that it may be taken regularly,
twice per day; it is not effective for the relief of an acute asthma attack.
- clinicians should continue to be aware of the possible risks associated
with the long-term use of long-acting beta2 agonists (LABAs, i.e. salmeterol
- should be used only in conjunction with inhaled corticosteroids
- for the management of chronic asthma, LABAs should:
- be added only if regular use of standard-dose inhaled corticosteroids
has failed to control asthma adequately;
- not be initiated in patients with rapidly deteriorating asthma;
- be introduced at a low dose and the effect properly monitored before
considering dose increase;
- be discontinued in the absence of benefit;
- be reviewed as clinically appropriate: stepping down therapy should
be considered when good long-term asthma control has been achieved
Last reviewed 01/2018